Note: This document contains side effect information about besifloxacin ophthalmic. Some dosage forms listed on this page may not apply to the brand name Besivance.
Applies to besifloxacin ophthalmic: ophthalmic suspension.
Serious side effects of Besivance
Along with its needed effects, besifloxacin ophthalmic (the active ingredient contained in Besivance) may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.
Check with your doctor immediately if any of the following side effects occur while taking besifloxacin ophthalmic:
Less common
- Blurred vision
- eye pain
- itching of the eye
- red, sore eyes
- swelling of the eye or eyelid
Other side effects of Besivance
Some side effects of besifloxacin ophthalmic may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.
Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:
Less common
- Headache
For Healthcare Professionals
Applies to besifloxacin ophthalmic: ophthalmic suspension.
Ocular
Common (1% to 10%): Conjunctival redness, blurred vision, eye pain, eye irritation, eye pruritus, conjunctivitis, bacterial conjunctivitis
Uncommon (0.1% to 1%): Eyelid edema, conjunctival edema, corneal infiltrates, punctate keratitis, eye discharge, conjunctival hemorrhage, conjunctival disorder, dry eye, limbal hyperemia, conjunctival hyperemia, viral conjunctivitis, ocular hyperemia, reduced visual acuity, eyelid erythema, keratoconjunctivitis sicca, corneal staining, eyelid margin crusting
Postmarketing reports: Corneal deposits, corneal disorders, corneal edema, corneal opacity, corneal striae, eye edema, foreign-body sensation in eyes, increased lacrimation, ocular discomfort, photophobia, corneal dystrophy, anterior chamber disorder, blepharitis, corneal pigmentation, corneal scar, corneal thickening, eye inflammation, eye swelling, glare, halo vision, meibomian gland dysfunction, strabismus, ulcerative keratitis, visual impairment, endophthalmitis, hypopyon, corneal flap complication, diffuse lamellar keratitis, eye burn, eye injury, foreign body in eye, increased intraocular pressure, abnormal visual acuity test[Ref]
Nervous system
Common (1% to 10%): Headache
Postmarketing reports: Dizziness, dysgeusia, presyncope[Ref]
Other
Uncommon (0.1% to 1%): Otitis media, ear infection
Postmarketing reports: Off-label use, impaired healing, medication residue, edema, drug ineffective (including for unapproved indication), gait disturbance, malaise, peripheral edema, pyrexia, candidiasis, staphylococcal infection, inappropriate schedule of drug administration, incorrect dose administered, incorrect drug dose form administered[Ref]
Respiratory
Uncommon (0.1% to 1%): Sinusitis, nasopharyngitis, upper respiratory tract infection, pharyngolaryngeal pain, nasal congestion, respiratory tract congestion, asthma, cough
Postmarketing reports: Dry throat, dyspnea, throat tightness[Ref]
Psychiatric
Uncommon (0.1% to 1%): Depression
Postmarketing reports: Disorientation, insomnia[Ref]
Cardiovascular
Postmarketing reports: Increased blood pressure, endothelial dysfunction[Ref]
Dermatologic
Postmarketing reports: Cold sweat, madarosis, photosensitivity reaction[Ref]
Gastrointestinal
Postmarketing reports: Diarrhea, dysphagia, frequent bowel movements, gingival pain, glossodynia, mucous stools, nausea, sensitivity of teeth[Ref]
Local
Postmarketing reports: Instillation site pain[Ref]
Metabolic
Postmarketing reports: Increased blood glucose, hypokalemia[Ref]
Musculoskeletal
Postmarketing reports: Muscle spasm[Ref]
